The “Prix Galien de Pharmacologie” 2016 awarded to Julien Hanson, researcher at ULg

The “Prix Galien de Pharmacologie” 2016 awarded to Julien Hanson, researcher at ULg

The “prix Galien de Pharmacologie” is organized each year in Belgium by the “Journal du Médecin”. It awards a work in fundamental or clinical Pharmacology that has been accomplished by a researcher or a team of researchers below the age of 40.

The Prix Galien de Pharmacologie 2016 (awarded in 2017) was awarded to Julien Hanson for his contribution to the study of understudied G protein coupled receptors. Julien Hanson is a Research Associates at the F.R.S.-FNRS and heads the Laboratory of Molecular Pharmacology based at the GIGA (Molecular Biology of Disease) and the CIRM (Medicinal Chemistry). G protein-coupled receptors (GPCR) are the main effectors for the transmission of extracellular signals and are involved in virtually any physiological processes, from vision to cardiac rhythm regulation or neurotransmission. Their key roles in the functioning of our physiology have made them prime targets for many drugs. It is estimated that 60% of the molecules used for therapeutic purposes have a mechanism of action that involves at least one GPCR. However, surprisingly, the majority of the 800 GPCRs that compose our genome have an unknown function. Because of their therapeutic efficacy, fundamental research on understudied receptors is required for the development of innovative drugs. The award-winning research focuses on these poorly characterized receptors, whether they are “orphans” (without described ligands) or without a well-defined function.

Related articles

PDC*line Pharma is GMP accredited by the Belgian Federal Agency for Medicines and Health Products (FAMHP) for its Quality Control and Release Activities for PDC*lung, a drug for lung cancer immunotherapy

Liège (Belgium), 21st January 2019. PDC*line Pharma is delighted to announce, that the company is now accredited by the Belgian Federal Agency for Medicines and Health Products (FAMHP) for the Quality Control and Release activities of its anticancer agent PDC*lung, intended for the treatment of patients with lung cancer.  PDC*line Pharma is developing a new

Read more
PDC*line Pharma is GMP accredited by the Belgian Federal Agency for Medicines and Health Products (FAMHP) for its Quality Control and Release Activities for PDC*lung, a drug for lung cancer immunotherapy

First Congress in Health Simulation

The Medical Simulation Center of the University of Liège organizes its first congress in Health Simulation: “Towards evidence-based simulation”. Event will be held on Thursday, March 28th, 2019 in the faculty of medicine amphitheatres of Liège University, located on Sart-Tilman campus. Several themes will be discussed: Evidence-based Innovations and advances in simulation Medical education –

Read more
First Congress in Health Simulation

New University Certificate for clinical trials

The Clinical Sciences Department of the Medicine Faculty of the University of Liège organizes from the academic year 2018-2019 a University Certificate in clinical trials. More information is available in this folder

Read more
New University Certificate for clinical trials